Moderna signed distribution agreement with GC Pharma for its COVID-19 vaccine in Korea, and GC Pharma has the final copyright.

On the 26th, GC Pharma was a successful bidder as a domestic pharmaceutical company in charge of licensing and distribution of Moderna’s mRNA-1273 vaccine. GC Pharma's CEO Eun-cheol Huh bids for ₩34.2 billion.

GC Pharma has completed the procedure for approval by the MFDS and national lot release for the domestic market approval of Moderna vaccine in the future. And it will be in charge of supplying 40 million doses of government vaccines.

GC Pharma is expected to distribute vaccines sold to the general market in addition to the government's